JP2014512364A5 - - Google Patents

Download PDF

Info

Publication number
JP2014512364A5
JP2014512364A5 JP2014504078A JP2014504078A JP2014512364A5 JP 2014512364 A5 JP2014512364 A5 JP 2014512364A5 JP 2014504078 A JP2014504078 A JP 2014504078A JP 2014504078 A JP2014504078 A JP 2014504078A JP 2014512364 A5 JP2014512364 A5 JP 2014512364A5
Authority
JP
Japan
Prior art keywords
substituted
group
monomer
alkyl
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014504078A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014512364A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/032809 external-priority patent/WO2013058824A1/en
Publication of JP2014512364A publication Critical patent/JP2014512364A/ja
Publication of JP2014512364A5 publication Critical patent/JP2014512364A5/ja
Pending legal-status Critical Current

Links

JP2014504078A 2011-04-07 2012-04-09 水溶液中で二量体化できる単量体、およびその使用法 Pending JP2014512364A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161473093P 2011-04-07 2011-04-07
US61/473,093 2011-04-07
PCT/US2012/032809 WO2013058824A1 (en) 2011-04-07 2012-04-09 Monomers capable of dimerizing in an aqueous solution, and methods of using same

Publications (2)

Publication Number Publication Date
JP2014512364A JP2014512364A (ja) 2014-05-22
JP2014512364A5 true JP2014512364A5 (enExample) 2015-05-28

Family

ID=48141232

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014504078A Pending JP2014512364A (ja) 2011-04-07 2012-04-09 水溶液中で二量体化できる単量体、およびその使用法

Country Status (4)

Country Link
US (2) US20140194383A1 (enExample)
EP (1) EP2694707B1 (enExample)
JP (1) JP2014512364A (enExample)
WO (1) WO2013058824A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140194383A1 (en) 2011-04-07 2014-07-10 Cornell University Monomers capable of dimerizing in an aqueous solution, and methods of using same
WO2013058825A1 (en) 2011-04-07 2013-04-25 Cornell University Silyl monomers capable of multimerizing in an aqueous solution, and methods of using same
DK2950644T3 (en) 2013-01-30 2017-09-04 Agrofresh Inc USE OF BENZOXABOROLS AS VOLATIVE ANTIMICROBIAL AGENTS IN MEAT, PLANTS OR PARTS
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
CN103880679B (zh) * 2014-03-13 2015-02-11 河北科技大学 3-乙氧基-4-乙氧羰基苯乙酸的合成方法
CN105017140B (zh) * 2014-04-28 2017-12-29 复旦大学 邻氨基苯甲酰胺化合物及其制备方法和用途
WO2016115360A1 (en) * 2015-01-14 2016-07-21 Coferon, Inc. C-myc ligands capable of dimerizing in an aqueous solution, and methods of using same
CA2985823A1 (en) 2015-05-12 2016-11-17 Blinkbio, Inc. Silicon based drug conjugates and methods of using same
GB201603359D0 (en) * 2016-02-26 2016-04-13 Binding Site Group The Ltd Improved assay
NZ745681A (en) 2016-03-07 2022-05-27 Agrofresh Inc Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
WO2017214491A1 (en) 2016-06-09 2017-12-14 Blinkbio, Inc. Silanol based therapeutic payloads
CN107573297A (zh) * 2017-08-31 2018-01-12 桂林南药股份有限公司 一种利奈唑胺的酸性水解杂质的制备方法
CN109678701B (zh) * 2019-01-22 2021-08-20 安徽德信佳生物医药有限公司 一种维兰特罗中间体的制备方法
ES2951876T3 (es) * 2019-07-17 2023-10-25 Shinetsu Chemical Co Compuesto diéster que tiene un anillo de dimetilciclobutano, un procedimiento para preparar el mismo, y un procedimiento para preparar compuesto de dimetilciclobutano derivado del compuesto diéster
JP7335849B2 (ja) * 2019-07-17 2023-08-30 信越化学工業株式会社 ジメチルシクロブタン環を有するジエステル化合物及びその製造方法、並びにそれから誘導されるジメチルシクロブタン化合物の製造方法
KR20220119052A (ko) * 2019-12-20 2022-08-26 아뷰터스 바이오파마 코포레이션 합성 공정 및 중간체
US20230285570A1 (en) * 2020-08-07 2023-09-14 Cornell University Therapeutically useful cure-pro molecules for e3 ligase mediated degradation of proteins, and methods of making and using them
WO2022031772A1 (en) * 2020-08-07 2022-02-10 Cornell University Therapeutic composition of cure-pro compounds for targeted degradation of bet domain proteins, and methods of making and usage
CN114315787A (zh) * 2021-12-30 2022-04-12 广州佳途科技股份有限公司 一种维兰特罗ep杂质2的制备方法及应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63222153A (ja) 1987-03-11 1988-09-16 Kanegafuchi Chem Ind Co Ltd 新規α−シアノケイ皮酸アミド誘導体
US5236919A (en) 1989-02-28 1993-08-17 Imperial Chemical Industries Plc Quinoxalinyl derivatives suitable for use in leukotriene mediated disease
EP0918069B1 (en) 1997-05-30 2008-04-09 Shiseido Company Limited Composition containing a copolymer comprising reactive silyl groups and application methods of the same
ATE317122T1 (de) 1997-09-05 2006-02-15 Matsushita Electric Industrial Co Ltd Fluoreszierende polarisation
US6326478B1 (en) 1998-07-08 2001-12-04 Isis Pharmaceuticals, Inc. Process for the synthesis of oligomeric compounds
OA12274A (en) 2000-05-22 2006-05-09 Aventis Pharma Inc Arylmethylamine derivatives for use as tryptase inhibitors.
GB0012362D0 (en) * 2000-05-22 2000-07-12 Aventis Pharma Ltd Chemical compounds
GB0111459D0 (en) 2001-05-10 2001-07-04 Isis Innovation Universal fluorescent sensors
US20100081792A1 (en) 2001-06-28 2010-04-01 Smithkline Beecham Corporation Ligand
JP3841398B2 (ja) 2001-12-17 2006-11-01 富士写真フイルム株式会社 ネガ型レジスト組成物
WO2004071641A2 (en) 2003-02-10 2004-08-26 Pointilliste, Inc. Self-assembling arrays and uses thereof
EP2716647A3 (en) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
US7511139B2 (en) 2004-06-04 2009-03-31 Bristol-Myers Squibb Company Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation
TW200800201A (en) 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
US8129366B2 (en) 2005-12-13 2012-03-06 Daiichi Sankyo Company, Limited VLA-4 inhibitory drug
EP1963273A2 (en) 2005-12-22 2008-09-03 Wyeth a Corporation of the State of Delaware Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitors
US8239008B2 (en) 2007-04-13 2012-08-07 Ethicon Endo-Surgery, Inc. Sentinel node identification using fluorescent nanoparticles
CN101952719A (zh) 2007-07-27 2011-01-19 通信改革公司 检测测定法及其用途
UA108596C2 (xx) 2007-11-09 2015-05-25 Інгібітори пептиддеформілази
ES2469824T3 (es) 2007-11-21 2014-06-20 Janssen Pharmaceutica N.V. Espiropiperidinas para su uso como inhibidores de la triptasa
ES2396366T3 (es) 2007-12-10 2013-02-21 Concert Pharmaceuticals Inc. Inhibidores heterocíclicos de quinasas
US8853185B2 (en) 2008-04-09 2014-10-07 Cornell University Coferons and methods of making and using them
FR2955324A1 (fr) * 2010-01-15 2011-07-22 Sanofi Aventis [4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones disubstituees
CA2774476A1 (en) * 2009-10-07 2011-04-14 Francis Barany Coferons and methods of making and using them
US20140194383A1 (en) 2011-04-07 2014-07-10 Cornell University Monomers capable of dimerizing in an aqueous solution, and methods of using same
WO2013058825A1 (en) 2011-04-07 2013-04-25 Cornell University Silyl monomers capable of multimerizing in an aqueous solution, and methods of using same
WO2012154213A1 (en) 2011-04-07 2012-11-15 Cornell University Cofluorons and methods of making and using them

Similar Documents

Publication Publication Date Title
CN112912077B (zh) 用于治疗三阴性乳腺癌的组合疗法
RU2477723C2 (ru) Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
US8921565B2 (en) Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
AU2022203611A1 (en) Spray dry formulations
ES2911040T3 (es) Nuevos derivados de heteroaril amida como inhibidores selectivos de histona deacetilasa 1 y 2 (HDAC1/2)
JP2020535218A (ja) SHP2のオクタヒドロシクロペンタ[c]ピロールのアロステリック阻害剤
JP2011515397A5 (enExample)
CA2990192A1 (en) Compositions and methods for inhibiting arginase activity
CN102149683B (zh) 1-(取代苄基)-5-三氟甲基-2-(1h)吡啶酮化合物及其盐,其制备方法及其用途
JP2015524472A5 (enExample)
JP7778745B2 (ja) Rho関連コイルドコイル含有プロテインキナーゼの阻害剤
JP2014521653A5 (enExample)
JP2022519237A (ja) Dnaポリメラーゼシータ阻害剤としてのアセトアミド誘導体
WO2014145642A9 (en) Nrf2 small molecule inhibitors for cancer therapy
JP2010524952A5 (enExample)
WO2011003191A1 (en) Compositions and methods for enhancing virus efficacy
TW201733580A (zh) Trk抑制劑抵抗性的癌治療劑
JP2016525104A5 (enExample)
JP2014511865A5 (enExample)
JP2015515465A5 (enExample)
EA032697B1 (ru) Амидогетероарилароилгидразидэтины
JP7027324B2 (ja) 増殖性疾病の組み合せ療法
JP2010535203A5 (enExample)
JP2025087773A (ja) Rho関連コイルドコイル含有プロテインキナーゼの阻害剤
JP2013532146A5 (enExample)